American Well Co. (NYSE:AMWL) Director Stephen J. Schlegel Sells 5,054 Shares of Stock

American Well Co. (NYSE:AMWL – Get Rating) Director Stephen J. Schlegel sold 5,054 shares of the stock in a transaction dated Wednesday, June 15th. The stock was sold at an average price of $4.13, for a total value of $20,873.02. Following the transaction, the director now directly owns 95,261 shares in the company, valued at approximately $393,427.93. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of NYSE AMWL opened at $4.13 on Friday. The stock’s 50-day moving average is $3.51 and its two-hundred day moving average is $4.31. American Well Co. has a 1-year low of $2.52 and a 1-year high of $14.05.

American Well (NYSE:AMWL – Get Rating) last released its quarterly earnings data on Monday, May 9th. The company reported ($0.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.04). American Well had a negative net margin of 79.91% and a negative return on equity of 16.72%. The business had revenue of $64.20 million during the quarter, compared to analysts’ expectations of $64.94 million. During the same quarter in the previous year, the company posted ($0.16) EPS. The company’s revenue was up 11.5% compared to the same quarter last year. On average, research analysts expect that American Well Co. will post -0.98 earnings per share for the current fiscal year.

AMWL has been the topic of several research reports. Guggenheim initiated coverage on American Well in a research note on Wednesday, April 13th. They set a “buy” rating and a $6.00 target price on the stock. Wells Fargo & Company decreased their target price on American Well from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research note on Monday, February 28th. Finally, Piper Sandler reissued an “overweight” rating and set a $5.00 target price (down previously from $7.00) on shares of American Well in a research note on Monday, May 16th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, American Well currently has an average rating of “Buy” and a consensus price target of $8.89.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Strs Ohio increased its holdings in shares of American Well by 80.1% in the 4th quarter. Strs Ohio now owns 49,000 shares of the company’s stock valued at $295,000 after acquiring an additional 21,800 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in shares of American Well in the 4th quarter valued at about $234,000. State Board of Administration of Florida Retirement System increased its holdings in shares of American Well by 10.7% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 58,394 shares of the company’s stock valued at $353,000 after acquiring an additional 5,656 shares during the last quarter. Cannell & Co. purchased a new position in shares of American Well in the 4th quarter valued at about $100,000. Finally, Wolf Group Capital Advisors increased its holdings in shares of American Well by 200.0% in the 4th quarter. Wolf Group Capital Advisors now owns 138,309 shares of the company’s stock valued at $835,000 after acquiring an additional 92,206 shares during the last quarter. Institutional investors and hedge funds own 43.75% of the company’s stock.

American Well Company Profile (Get Rating)

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.

Featured Stories

• Get a free copy of the StockNews.com research report on American Well (AMWL)
• Vuzix Stock Stays Optimistic
• Palo Alto Networks: Pioneering AI in Cybersecurity
• Dividend Stocks and Your Roth IRA
• The Analysts Upgrade… Retail Stocks? 
• The Q2 Earnings Season Could Be A Bloodbath 

Want More Great Investing Ideas?